- Repare Therapeutics Provides Business and Clinical Update and Reports First Quarter 2024 Financial Results
- Debiopharm & Repare Therapeutics Announce First Patient Dosed in Phase 1/1b Mythic Trial Evaluating the Synthetic Lethal Combination of WEE1 AND PKMYT1 Inhibition
- Repare Therapeutics & Debiopharm Announce First Patient Dosed in Phase 1/1b MYTHIC Trial Evaluating the Synthetic Lethal Combination of PKMYT1 and WEE1 Inhibition
- Repare Therapeutics Appoints Steven H. Stein, M.D. to its Board of Directors
- Repare Therapeutics to Participate in Two Upcoming Investor Conferences
- Repare Therapeutics Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
More ▼
Key statistics
As of last trade Repare Therapeutics Inc (RPTX:NSQ) traded at 3.14, 5.20% above its 52-week low of 2.98, set on Apr 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 3.09 |
---|---|
High | 3.25 |
Low | 3.05 |
Bid | 3.12 |
Offer | 3.15 |
Previous close | 3.10 |
Average volume | 256.27k |
---|---|
Shares outstanding | 42.45m |
Free float | 42.03m |
P/E (TTM) | -- |
Market cap | 131.58m USD |
EPS (TTM) | -1.10 USD |
Data delayed at least 15 minutes, as of May 24 2024 19:27 BST.
More ▼